ARID1A and neuroblastoma: Among the genes not previously known to be involved in neuroblastoma, deletions and sequence alterations of the chromatin-remodeling genes ARID1A and ARID1B were identified in 11% (8 of 71 tumors), and these aberrations correlated with a more aggressive phenotype (17).